EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW 12,190
-20 (-0.16%)
Dec 10, 2025, 3:30 PM KST
EuBiologics Market Cap
EuBiologics has a market cap or net worth of 447.46 billion as of December 10, 2025. Its market cap has decreased by -21.54% in one year.
Market Cap
447.46B
Enterprise Value
n/a
Revenue
96.04B
Ranking
n/a
PE Ratio
18.00
Stock Price
12,190.00
Market Cap Chart
Since January 24, 2017, EuBiologics's market cap has increased from 122.86B to 447.46B, an increase of 264.22%. That is a compound annual growth rate of 15.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 447.46B | 0.80% |
| Dec 30, 2024 | 443.89B | 6.16% |
| Dec 28, 2023 | 418.14B | 28.91% |
| Dec 29, 2022 | 324.36B | -74.49% |
| Dec 30, 2021 | 1.27T | 93.99% |
| Dec 30, 2020 | 655.40B | 209.65% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |